Facts About Filing A Zantac Cancer Lawsuit

Legal experts think that thousands of Zantac Cancer sufferers may file claims for monetary damage compensation in 2021

Friday, January 8, 2021 - If you or a loved one have been diagnosed with cancer of the stomach, bladder, intestines, or other cancer, and have taken the anti-heartburn and acid reflux medicine Zantac, you should seek the guidance of a Zantac Cancer Lawyer and possibly file a claim. Sanofi, the maker of Zantac, has been accused by more than 500 Zantac users with cancer in 2020 for failing to warn them of the dangers NDMA presented to their health among other allegations. Attorneys representing Zantac cancer plaintiffs could be required to provide information specific to their experience with the antacid and cancer they have developed. Zantac cancer plaintiffs should be prepared to demonstrate the dates they took the drug with either pharmacy receipts which could be listed on a monthly bank statement. They also should know the dates and the doctor that made their initial cancer diagnosis. The plaintiff should be able to provide the date they stopped working if seeking compensation for lost wages. The plaintiff should also secure their hospital and doctor medical records to be reimbursed for medical expenses.

Lawsuits against Sanofi have been consolidated into multidistrict litigation to save time and to streamline the presentation of the complex science underlying Zantac cancer contamination. MDL plaintiffs' cases are considered individually and should not be confused with a class-action lawsuit. Plaintiffs claim Zantac caused their "bladder cancer and bladder removal, breast cancer, colon cancer, esophageal cancer, kidney cancer and kidney removal, liver cancer, melanoma, ovarian cancer, prostate cancer, and stomach cancer, " according to DrugWatch.com. The first trials could begin in 2021. Experts predict that by 2022 bellwether trials will have provided an indication of the size of the likely jury awards and also an indication of Sanofi's willingness to settle the cases out of court.

Sanofi is being accused in a federal government investigation of deliberately covering up their knowledge of high, carcinogenic levels of NDMA from federal regulators, the medical community, and the public. During this period of about 20 years, Zantac became the best-selling antacid treatment selling their product over the counter and by doctor's prescription. On April 1, 2020, the US Food and Drug Administration ordered Sanofi to stop selling Zantac, the drug removed from store shelves, and that doctors stop prescribing the drug.

At the core of Zantac cancer concerns is the chemical compound N-Nitrosodimethylamine, also known as dimethylnitrosamine. According to the CDC, NDMA is a dangerous carcinogen whose use was to induce tumors in laboratory animals used for cancer research. "It is a yellow liquid which has no distinct odor. It is produced in the U.S. only for use as a research chemical. NDMA was used to make rocket fuel, but this use was stopped after unusually high levels of this compound were found in air, water, and soil samples collected near a rocket fuel manufacturing plant." Online pharmacy Valisure tested Zantac and found it contained more than 3,000,000 NGS of NDMA, far exceeding the FDA's guideline of no more than 96ngs per tables. The results were immediately brought to the attention of Sanofi and the FDA. Sanofi pulled the product from store shelves, and the FDA initiated the ban about a month later.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.